Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruchi Chaudhary

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumorsRavit Geva, Maria Vieito, Jorge Ramon, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology ConsortiumFrancesca Fenizia, Ilaria Alborelli, Jose Luis Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2025
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I StudyMark N Stein, Armelle Vinceneux, Debbie Robbrecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2015
Synthesis of phylogeny and taxonomy into a comprehensive tree of lifeCody E Hinchliff, Stephen A Smith, James F Allman, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.
Advanced Biology|July 10, 2022
Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from IndiaPrashanth Lingappa Kukkle, Thenral S Geetha, Ruchi Chaudhary, et al.
Nature Communications|June 8, 2023
South Asian medical cohorts reveal strong founder effects and high rates of homozygosityJeffrey D Wall, J Fah Sathirapongsasuti, Ravi Gupta, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumorsRavit Geva, Maria Vieito, Jorge Ramon, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology ConsortiumFrancesca Fenizia, Ilaria Alborelli, Jose Luis Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2025
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I StudyMark N Stein, Armelle Vinceneux, Debbie Robbrecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2015
Synthesis of phylogeny and taxonomy into a comprehensive tree of lifeCody E Hinchliff, Stephen A Smith, James F Allman, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.
Advanced Biology|July 10, 2022
Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from IndiaPrashanth Lingappa Kukkle, Thenral S Geetha, Ruchi Chaudhary, et al.
Nature Communications|June 8, 2023
South Asian medical cohorts reveal strong founder effects and high rates of homozygosityJeffrey D Wall, J Fah Sathirapongsasuti, Ravi Gupta, et al.
Pageof 2